Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Catalent, Inc.CTLT · Entity 16279 | Director | November 21, 2017 | November 22, 2017 |
| PERRIGO Co plcPRGO · Entity 4516 | Director · CEO | March 08, 2018 | March 12, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Catalent, Inc.
Report date November 21, 2017 · Filed November 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,489 |
Reported balance
After 2017-11-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-11-21 · Purchase · Acquired 7,500 · Balance 16,489 F1: Represents the purchase price of EUR33.294 converted into U.S. dollars at the exchange rate of 1 Euro to US$1.1781, as in effect on November 21, 2017. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the purchase price of EUR33.294 converted into U.S. dollars at the exchange rate of 1 Euro to US$1.1781, as in effect on November 21, 2017.
F2: Includes restricted stock units.
PERRIGO Co plc
Report date March 08, 2018 · Filed March 12, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $85.06 · Expires 2028-03-08 | Direct | 72,149 |
Reported balance
After 2018-03-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-03-08 · Grant · Acquired 72,149 · Balance 72,149 F1: Exercisable in 3 equal annual installments beginning 3/8/2019. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2018-03-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,500 |
Filing footnotes · ownership attribution and instrument terms
F1: Exercisable in 3 equal annual installments beginning 3/8/2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2018 Filed Mar 12, 2018 19:42 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantEmployee Stock Option Right to Buy · Derivative | 72,149 | $85.06 Strike: $85.06 | $6,136,993.94 |
DisclosureSEC source: 0001689340-18-000007 · wf-form4_152089815026408.xml · derivative · entry 2 Roehrhoff Uwe · CIK 0001689340 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,149 Underlying: Ordinary Shares · 72,149 shares Expires 2028-03-08 F1 · derivative.exercise_date: Exercisable in 3 equal annual installments beginning 3/8/2019. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 16:46 UTC | PERRIGO Co plc PRGO · Entity 4516 | PurchaseOrdinary Shares | 2,600 | $82.43 | $214,306.30 |
DisclosureSEC source: 0001689340-18-000006 · wf-form4_152045917126472.xml · nonDerivative · entry 2 Roehrhoff Uwe · CIK 0001689340 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $[82.1400] to $[82.6500], inclusive. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 16:46 UTC | PERRIGO Co plc PRGO · Entity 4516 | PurchaseOrdinary Shares | 4,900 | $81.54 | $399,556.29 |
DisclosureSEC source: 0001689340-18-000006 · wf-form4_152045917126472.xml · nonDerivative · entry 1 Roehrhoff Uwe · CIK 0001689340 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $[81.0200] to $[81.9600], inclusive. The reporting person undertakes to provide to Perrigo Company plc, any security holder of Perrigo Company plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 18:28 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 5,721 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001689340-18-000003 · wf-form4_151631812109158.xml · derivative · entry 2 Roehrhoff Uwe · CIK 0001689340 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,721 Underlying: Ordinary Shares · 5,721 shares Expires 2020-01-16 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 16:25 UTC | Catalent, Inc. CTLT · Entity 16279 | PurchaseCommon Stock | 7,500 | $39.22 | $294,150.00 |
DisclosureSEC source: 0001596783-17-000176 · wf-form4_151138591363691.xml · nonDerivative · entry 1 Roehrhoff Uwe · CIK 0001689340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,489 F1 · price: Represents the purchase price of EUR33.294 converted into U.S. dollars at the exchange rate of 1 Euro to US$1.1781, as in effect on November 21, 2017. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:32 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 3,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000130 · wf-form4_150393431407697.xml · nonDerivative · entry 1 Roehrhoff Uwe · CIK 0001689340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,989 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package adopted in 2014. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 14:39 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 2,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-17-000013 · wf-form4_148640993813494.xml · nonDerivative · entry 1 Roehrhoff Uwe · CIK 0001689340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,013 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units (pro-rated to reflect a partial year of service) provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package adopted in 2014. F2 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.